Company Registration No. 12685645 (England and Wales)
CAPLET PHARMA LIMITED
Unaudited accounts
for the year ended 30 June 2025
CAPLET PHARMA LIMITED
Unaudited accounts
Contents
CAPLET PHARMA LIMITED
Company Information
for the year ended 30 June 2025
Director
Purvi Chirag Shah
Company Number
12685645 (England and Wales)
Registered Office
133-135 HIGH ROAD
LONDON
N11 1PP
ENGLAND
CAPLET PHARMA LIMITED
Statement of financial position
as at 30 June 2025
Tangible assets
1,055,781
1,056,015
Inventories
101,182
21,513
Cash at bank and in hand
16,342
109,587
Creditors: amounts falling due within one year
(281,006)
(309,340)
Net current liabilities
(17,154)
(79,353)
Total assets less current liabilities
1,038,627
976,662
Creditors: amounts falling due after more than one year
(699,130)
(763,714)
Net assets
339,497
212,948
Called up share capital
100
100
Profit and loss account
339,397
212,848
Shareholders' funds
339,497
212,948
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 August 2026 and were signed on its behalf by
Purvi Chirag Shah
Director
Company Registration No. 12685645
CAPLET PHARMA LIMITED
Notes to the Accounts
for the year ended 30 June 2025
CAPLET PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 12685645. The registered office is 133-135 HIGH ROAD, LONDON, N11 1PP, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20%RBM
4
Tangible fixed assets
Land & buildings
Motor vehicles
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At cost
At 1 July 2024
1,045,879
13,200
658
1,385
1,061,122
Additions
-
-
583
1,228
1,811
Disposals
-
(1,839)
-
-
(1,839)
At 30 June 2025
1,045,879
11,361
1,241
2,613
1,061,094
At 1 July 2024
-
4,007
348
752
5,107
Charge for the year
-
-
72
134
206
At 30 June 2025
-
4,007
420
886
5,313
At 30 June 2025
1,045,879
7,354
821
1,727
1,055,781
At 30 June 2024
1,045,879
9,193
310
633
1,056,015
CAPLET PHARMA LIMITED
Notes to the Accounts
for the year ended 30 June 2025
Amounts falling due within one year
Other debtors
69,293
98,887
6
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
88,236
110,000
Taxes and social security
46,671
51,432
Other creditors
146,099
4,200
7
Creditors: amounts falling due after more than one year
2025
2024
Bank loans
699,130
763,714
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).